+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 266 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 5791059
The Medical Devices sector report, “Coronary Stents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent system consists of a stent and balloon catheter delivery system.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Coronary Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Coronary Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Coronary Stents Overview
3 Products under Development
3.1 Coronary Stents - Pipeline Products by Stage of Development
3.2 Coronary Stents - Pipeline Products by Segment
3.3 Coronary Stents - Pipeline Products by Territory
3.4 Coronary Stents - Pipeline Products by Regulatory Path
3.5 Coronary Stents - Pipeline Products by Estimated Approval Date
3.6 Coronary Stents - Ongoing Clinical Trials
4 Coronary Stents - Pipeline Products under Development by Companies
4.1 Coronary Stents Companies - Pipeline Products by Stage of Development
4.2 Coronary Stents - Pipeline Products by Stage of Development
5 Coronary Stents Companies and Product Overview6 Coronary Stents- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Coronary Stents - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Segment
  • Coronary Stents - Pipeline Products by Territory
  • Coronary Stents - Pipeline Products by Regulatory Path
  • Coronary Stents - Pipeline Products by Estimated Approval Date
  • Coronary Stents - Ongoing Clinical Trials
  • Coronary Stents Companies - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Coronary Stents - Pipeline Products by Stage of Development
  • Coronary Stents - Pipeline Products by Segment
  • Coronary Stents - Pipeline Products by Territory
  • Coronary Stents - Pipeline Products by Regulatory Path
  • Coronary Stents - Pipeline Products by Estimated Approval Date
  • Coronary Stents - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Vascular Inc
  • Adcomp Technologies Inc.
  • Advanced Bifurcation Systems Inc
  • Aeon Bioscience
  • Albert Einstein College of Medicine
  • Amaranth Medical Inc
  • Arterius Ltd
  • Atrium Medical Corp
  • Axordia Ltd (Inactive)
  • B. Braun Melsungen AG
  • Bactiguard Holding AB
  • Bionext Biotech Products Ltd.
  • Biosensors International Group Ltd
  • Biosten, LLC
  • Biotronik AG
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • Cardionovum GmbH
  • Cardiorev Pte Ltd (Inactive)
  • Columbia University
  • Concept Medical Inc
  • Contego Medical LLC
  • Cordis US Corp
  • Cytograft Tissue Engineering Inc (Inactive)
  • DISA Vascular (Pty) Ltd
  • Elixir Medical Corp
  • Endomimetics LLC
  • Envision Scientific Pvt Ltd
  • Georgia Institute of Technology
  • Global Vascular Co Ltd
  • HangZhou HuaAn Biotechnology Co., Ltd.
  • Hangzhou Juzheng Medical Technology Inc
  • I.B.S. S.p.A.
  • Icon Interventional Systems, Inc.
  • ID Nest Medical SAS
  • InspireMD Inc
  • Intressa Vascular SA
  • Japan Stent Technology Co., Ltd.
  • JW Medical Systems Ltd
  • Kaneka Corp
  • Kyoto Medical Planning Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • MangoGen Pharma Inc
  • Manli Cardiology Ltd
  • Medinol Ltd
  • Medlogics Device Corp (Inactive)
  • Medtronic Plc
  • Meril Life Sciences Pvt Ltd
  • Miami Cardiovascular Innovations
  • Micell Technologies Inc
  • Michigan Technological University
  • MicroPort Scientific Corp
  • Minvasys SAS
  • MIV Therapeutics Inc
  • NanoCoeur, Inc.
  • Nanova, Inc
  • Neovasc Inc
  • Nesstent Ltd.
  • Nexeon MedSystems Inc
  • North Carolina State University
  • Northwestern University
  • NuVascular Technologies Inc
  • OrbusNeich
  • Palmaz Scientific Inc (Inactive)
  • Pediastent LLC
  • QualiMed Innovative Medizinprodukte GmbH
  • Qvanteq AG
  • Relisys Medical Devices Ltd
  • REVA Medical Inc
  • Rontis AG
  • S3V Vascular Technologies
  • Sahajanand Medical Technologies Pvt Ltd
  • Shandong Rientech Medical Tech Co Ltd
  • Shanghai Bio-heart Biological Technology Co Ltd
  • Shanghai BIOMAGIC Medical Device Co Ltd
  • Shanghai Healing Medical Instruments Co Ltd
  • Shanghai MicroPort Medical Group Co Ltd
  • Shanghai MicroPort Rhythm MedTech Co Ltd
  • Sino Medical Sciences Technology Inc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stentys SA
  • Tepha Inc
  • Terumo Corp
  • Terumo Interventional Systems
  • TissueGen Inc
  • Translumina Therapeutics LLP
  • Tremedics Medical Devices LLC
  • TrendyMED Inc.
  • UAB Minority Health and Health Equity Research Center
  • University of Colorado
  • University of Florida
  • University of Galway
  • University of Michigan
  • University of Pittsburgh
  • University of Strathclyde
  • University of Utah
  • VahatiCor Inc
  • VasoTech Inc.
  • Viller Scientific LLC
  • Vital3D Technologies
  • Vornia Biomaterials Ltd
  • Xenogenics Corporation